The Effect of Remifentanil on ED95 of Remimazolam for Loss of Consciousness in Adult Patients

• Status: Not yet recruiting
• Trial end date: 2023-08-31
• Target enrollment: 0
• Participant gender: All

Summary

This study prospectively uses the biased coin technique to investigate the effect of concomitant administration of remifentanil on the 95% effective dose of intravenous remimazolam (Effective dose 95 [ED95]) required for loss of consciousness during anesthesia induction. .

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ajou University School of Medicine

Criteria

Inclusion Criteria:

• The adult patients who are scheduled to surgery under general anesthesia

Exclusion Criteria:

• Severe obesity (BMI > 30 kg/m2)

• Allergy to remimazolam or remifentanil

• Under conditions which make it difficult to respond to the investigator's verbal commends like hearing impairment, etc.

• Patients with general conditions are more than ASA class III

• Patients with brain disease (dementia, cerebral infarction, etc.)